Silencing of lncRNA TFAP2A-AS1 attenuates the development of acute coronary syndrome by inhibiting TFAP2A expression

Acute coronary syndrome (ACS), the acute manifestation of ischemic heart disease, remains a major cause of morbidity and mortality worldwide. The present study aimed to elucidate the preliminarily biological role and underlying mechanism of the long non-coding RNA (lncRNA) transcription factor AP-2α (TFAP2A)-AS1 in ACS. The viability, apoptosis, invasion, and migration of human coronary artery endothelial cells (HCAECs) were assessed using Cell Counting Kit-8, flow cytometric, Transwell, and wound healing assays. In addition, reverse transcription-quantitative PCR was performed to examine the expression levels of TFAP2A-AS1 and TFAP2A. Western blotting was performed to determine the protein level of TFAP2A. Furthermore, a mouse model of ACS was established to investigate the effects of TFAP2A-AS1 and TFAP2A on blood lipid levels. Histological changes were evaluated through hematoxylin and eosin staining. The results revealed high levels of TFAP2A-AS1 and TFAP2A expression in patients with ACS and in mouse models. In HCAECs, knockdown of TFAP2A-AS1 resulted in decreased TFAP2A expression, whereas silencing of TFAP2A did not affect the expression of TFAP2A-AS1. Interference with either TFAP2A-AS1 or TFAP2A in HCAECs led to suppressed cell viability, invasion, and migration, as well as an increased apoptosis rate. Furthermore, it was demonstrated that the absence of both TFAP2A-AS1 and TFAP2A reduced blood lipid levels and improved myocardial injury in a mouse model of ACS. In conclusion, groundbreaking findings revealed that the suppression of TFAP2A-AS1 could effectively mitigate the progression of ACS by reducing the expression of TFAP2A. This finding not only offers crucial insight into the pathogenesis of ACS but also provides a solid theoretical foundation for the development of novel therapeutic interventions in clinical settings.

• Publication year

  2025

• Venue

  Biomedical Reports

• Publication date

  2025-11-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/br.2025.2093PMID 41357815PMCID 12679535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated Levels of Circulating lncRNAs LIPCAR and MALAT1 Predict an Unfavorable Outcome in Acute Coronary Syndrome Patients

  2023cited by this paper
• Long non-coding RNA TFAP2A-AS1 plays an important role in oral squamous cell carcinoma: research includes bioinformatics analysis and experiments

  2022cited by this paper
• Long noncoding RNA TFAP2A-AS1 exerts promotive effects in non-small cell lung cancer progression via controlling the microRNA-548a-3p/CDK4 axis as a competitive endogenous RNA

  2022cited by this paper
• Long noncoding RNA TFAP2A‐AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR‐1297 and regulating TFAP2A expression

  2022cited by this paper
• High expression of lncRNA PELATON serves as a risk factor for the incidence and prognosis of acute coronary syndrome

  2022cited by this paper
• Targeting Circulating lncRNA ENST00000538705.1 Relieves Acute Coronary Syndrome via Modulating ALOX15

  2022cited by this paper
• Transcription factor KLF15 inhibits the proliferation and migration of gastric cancer cells via regulating the TFAP2A-AS1/NISCH axis

  2021cited by this paper
• AP-2 Family of Transcription Factors: Critical Regulators of Human Development and Cancer

  2021cited by this paper
• TFAP2A is a novel regulator that modulates ferroptosis in gallbladder carcinoma cells via the Nrf2 signalling axis.

  2020cited by this paper
• Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis

  2020cited by this paper
• 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

  2020cited by this paper
• Colchicine in Acute Coronary Syndrome: A Systematic Review

  2020influential reference
• MiR-204-5p/TFAP2A feedback loop positively regulates the proliferation, migration, invasion and EMT process in cervical cancer

  2020cited by this paper
• Noncoding RNAs as Biomarkers for Acute Coronary Syndrome

  2020cited by this paper
• 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

  2019cited by this paper
• Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2

  2019cited by this paper
• World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

  2019cited by this paper
• MicroRNA‐150 restores endothelial cell function and attenuates vascular remodeling by targeting PTX3 through the NF‐κB signaling pathway in mice with acute coronary syndrome

  2018cited by this paper
• Diagnosis and Management of Acute Coronary Syndrome: An Evidence-Based Update

  2015influential reference
• Requiem for the 'vulnerable plaque'.

  2015cited by this paper
• Global Perspective on Acute Coronary Syndrome: A Burden on the Young and Poor

  2014cited by this paper
• Incidence of heart failure and mortality after acute coronary syndromes.

  2013cited by this paper
• Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010.

  2012cited by this paper
• Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010.

  2012cited by this paper
• IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome.

  2011cited by this paper
• Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators

  2009cited by this paper
• Characterization of TBX20 in human hearts and its regulation by TFAP2

  2008cited by this paper
• One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database.

  2008cited by this paper
• Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations.

  2007cited by this paper
• Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2006cited by this paper
• Endothelial Dysfunction: A Marker of Atherosclerotic Risk

  2003cited by this paper
• Endothelial dysfunction, erectile dysfunction, and coronary heart disease: the pathophysiologic and clinical linkage.

  2003cited by this paper
• Vitamin C preserves endothelial function in patients with coronary heart disease after a high‐fat meal

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3.

  2000cited by this paper

• No citing papers are available for this paper.